Efficacy and Safety of Alisporivir Triple Therapy in Chronic Hepatitis C Genotype 1 Treatment-naïve Participants

NCT01318694 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1081

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Alisporivir
DRUG: Peginterferon alfa-2a
DRUG: Ribavirin
DRUG: ALV Placebo

Sponsor

Debiopharm International SA